InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Chevallard Daniel R., Chief Financial Officer. Insider active across 2 companies, notably Viracta Therapeutics, Inc.. In total, 8 filings have been published. The latest transaction was filed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
06,889 shares0
Common Stock
SEC:0001209191-22-032665:0·
06,889 shares0
Common Stock
SEC:0001209191-22-014438:0·
013,777 shares0
Common Stock
SEC:0001209191-21-067045·
013,777 shares0
Common Stock
SEC:0001209191-21-067045:0·
€7,70110,000 shares@ €0.770146.5% of flow
Common Stock
SEC:0001209191-21-058099·
€7,70110,000 shares@ €0.770146.5% of flow
Common Stock
SEC:0001209191-21-058099:0·
€8,85712,000 shares@ €0.738153.5% of flow
Common Stock
SEC:0001209191-21-036907·
€8,85712,000 shares@ €0.738153.5% of flow
Common Stock
SEC:0001209191-21-036907:0·
8 of 8 declarations
About Chevallard Daniel R.
Daniel R. Chevallard is Chief Financial Officer and Chief Operating Officer at Viracta Therapeutics, Inc. He is responsible for the company's financial management, overseeing financial operations and strategic planning. His role is crucial in ensuring the financial health of Viracta, ensuring the company meets its financial goals while navigating a complex environment.
